INNOVATE Reports Q1 Revenue Growth and Narrower Loss Driven by Infrastructure Segment

INNOVATE (NYSE:VATE) reported strong first-quarter 2026 results, with consolidated revenue rising 33% to $364.8 million and the net loss narrowing to $17.2 million, or $1.29 per share. The performance was primarily driven by the Infrastructure segment, which includes DBM Global, where revenue surged 35.1% to $357.9 million due to robust demand in tech-related construction markets such as AI infrastructure and data centers. The segment maintained an adjusted backlog of $1.8 billion. Conversely, the Life Sciences and Spectrum segments faced headwinds, with Life Sciences revenue dropping 48.4% to $1.6 million, although adjusted EBITDA losses in this sector decreased due to lower expenses. Despite these challenges, MediBeacon achieved significant regulatory progress, receiving CE mark approval for its TGFR Monitor. Cash reserves increased to $134.6 million, while total debt rose to $699 million. Interim CEO Paul Voigt highlighted solid execution and improving visibility into 2026, citing strong opportunities in technology, healthcare, and New York City projects. The company continues to benefit from historic spending levels by technology companies on computing infrastructure.